
What's Going On With Bleichroeder Acquisition Corp (BACQ) Stock Today?

I'm PortAI, I can summarize articles.
Bleichroeder Acquisition Corp (BACQ) shares are rising after Citron Research highlighted its favorable risk-reward profile. Citron claims BACQ could triple in value, emphasizing its merger partner, Merlin Labs, which has significant Pentagon contracts and a valuation of $800 million. The firm contrasts this with overvalued quantum computing stocks, suggesting BACQ offers downside protection with a net asset value floor at $10. BACQ shares are up 13.25% at $12.48, nearing a 52-week high.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

